Synergistic effects of d-chiro-inositol and manganese on blood glucose and body weight of streptozotocin-induced diabetic rats

Current Bioactive Compounds

Volumn 6, Issue 2, 2010, Pages 90-96

  Gluck, Gilbert ^a   Anguelova, Tatiana ^a   Heimark, Douglas ^b,c   Larner, Joseph ^b,c  

^a Cyvex Nutrition Inc   (United States)

^b Allomed Pharmaceuticals   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Chronic administration; D chiro inositol; Hyperglycemia; Manganese; Type 2 diabetes

Indexed keywords

CHIROSITOL; DEXTRO CHIRO INOSITOL; GLUCOSE; INOSITOL DERIVATIVE; INSULIN GLARGINE; MANGANESE SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

EID: 77954074340     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340710791184831     Document Type: Article

References (34)

1. Narayanan, C.R.; Joshi, D.D.; Mujumdar, A.M.; Dhekne, W. Pinitol -A new anti-diabetic compound from Bougainvillea spectabilis. Curr. Sci. (India), 1987, 56, 139-141.
2. Rubenstein, A.H.; Levin, N.W.; Elliott, G.A. Manganese-induced hypoglycaemia. Nature, 1962, 194, 188-189.
3. Kennington, A.S.; Hill, C.R.; Craig, J.; Bogardus, C.; Raz, I.; Ortmeyer, H.; Hansen, B.; Romero, G.; Larner, J. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med., 1990, 323, 373-378.
4. Asplin, I.; Galasko, G.; Larner, J. Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol-and the myoinositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type 2 diabetic subjects. Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 5924-5928.
5. Kazi, T.G.; Afridi, H.I.; Kazi, N.; Kazi, N.; Jamali, M.; Arain, M.; Jalbani, N.; Kandhro, G. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol. Trace Elem. Res., 2008, 122, 1-18.
6. Ekmekcioglu, C.; Prohaska, C.; Pomazal, K.; Steffan, I.; Schernthaner, G.; Marktl, W. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol. Trace Elem. Res., 2001, 79, 205-219.
7. Ortmeyer, H.K.; Huang, L.C.; Zhang, L.; Hansen, B.C.; Larner, J. Chiroinositol deficiency and insulin resistance. II. Acute effects of d-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulinresistant rhesus monkeys. Endocrinology, 1993, 132, 646-651.
8. Fonteles, M.C.; Almeida, M.Q.; Larner, J. Antihyperglycemic effects of 3-O-methyl-d-chiro-inositol and d-chiro-inositol associated with manganese in streptozotocin diabetic rats. Horm. Metab. Res., 2000, 32, 129-132.
9. Ortmeyer, H.K.; Larner, J.; Hansen, B.C. Effects of d-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys. Obes. Res., 1995, 3 Suppl. 4, 605S-608S.
10. Larner, J.; Allan, G.; Kessler, C.; Reamer, P.; Gunn, R.; Huang, L.C. Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy. In: Basic and Clinical Physiology and Pharmacology Special Issue Mechanisms of Insulin Resistance; Larner, J.; Taylor, S.I.; Eds.; Freund Publishers: London, 1998, Vol. 9, pp. 127-137.
11. Kim, J.I.; Kim, J.C.; Kang, M.J.; Lee, M.S.; Kim, J.J.; Cha, I.J. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type 2 diabetes mellitus: a randomized controlled study. Eur. J. Clin. Nutr., 2005, 59, 456-458.
12. Kim, M.J.; Yoo, K.H.; Park, H.S.; Chung, S.M.; CJ, C.; Choi, Y.S.; Chung, C.H. Effect of pinitol on glucose metabolism and adipocytokines in uncontrolled type 2 Diabetes Mellitus. J. Korean Diabetes Assoc., 2005, 29, 344-351.
13. Ku, B.J.; Kim, H.J.; Park, K.S. The clinical study to evaluate the safety and efficacy of d-chiro-inositol in patients with type 2 diabetes. Korean J. Med., 2007, 72, 29-36.
14. Baillargeon, J.-P.; Diamanti-Kandarakis, E.; Ostlund, R.E.; Apridonidze, T.; Iuorno, M.J.; Nestler, J.E. Altered d-chiroinositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care, 2006, 29, 300-305.
15. Bates, S.H.; Jones, R.B.; Bailey, C.J. Insulin-like effect of pinitol. Br. J. Pharmacol., 2000, 130, 1944-1948.
16. Park, J.H.; Lee, Y.J.; Kim, J.J.; Shin, Y.C.; Kim, J.C. The effect of pinitol on cataractogenesis and anti-oxidative effect in streptozotocin induced diabetic rats. J. Korean Ophthalmol. Soc., 2005, 46, 1886-1893.
17. Ortmeyer, H.K.; Bodkin, N.L.; Hansen, B.C.; Larner, J. In vivo dchiro-inositol activates skeletal muscle glycogen synthase and inactivates glycogen phosphorylase in rhesus monkeys. J. Nutr. Biochem., 1995, 6, 499-503.
18. Suzuki, S.; Kawasaki, H.; Satoh, Y.; Ohtomo, M.; Hirai, M.; Hirai, A.; Hirai, S.; Onoda, M.; Matsumoto, M.; Hinokio, Y. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type 2 diabetes. Diabetes Care, 1994, 17, 1465-1468.
19. Ekin, S.; Mert, N.; Gunduz, H.; Meral, I. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus. Biol. Trace Elem. Res., 2003, 94, 193-201.
20. Walter, R.M.J.; Uriu-Hare, J.Y.; Olin, K.L.; Oster, M.; Anawalt, B.; Critchfield, J.; Keen, C. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care, 1991, 14, 1050-1056.
21. Leonhardt, W.; Hanefeld, M.; Müller, G.; Hora, C.; Meissner, D.; Lattke, P.; Paetzold, A.; Jaross, W.; Schroeder, H. Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type 2 diabetes and control subjects. Clin. Chim. Acta, 1996, 254, 173-186.
22. Everson, G.J.; Shrader, R.E. Abnormal glucose tolerance in manganese-deficient guinea pigs. J. Nutr., 1968, 94, 89-94.
23. Zidenberg-Cherr, S.; Keen, C.L.; Lonnerdal, B.; Hurley, L.S. Superoxide dismutase activity and lipid peroxidation in the rat: developmental correlations affected by manganese deficiency. J. Nutr., 1983, 113, 2498-2504.
24. Baly, D.L.; Curry, D.L.; Keen, C.L.; Hurley, L.S. Effect of manganese deficiency on insulin secretion and carbohydrate homeostasis in rats. J. Nutr., 1984, 114, 1438-1446.
25. Nascimento, N.R.; Lessa, L.M.; Kerntopf, M.R.; Sousa, C.; Alves, R.; Queiroz, M.; Price, J.; Heimark, D.; Larner, J.; Du, X.; Brownlee, M.; Gow, A.; Davis, C.; Fonteles, M. Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 218-223.
26. Pak, Y.; Paule, C.R.; Bao, Y.D.; Huang, L.C.; Larner, J. Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor. Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 7759-7763.
27. Farese, R.V.; Standaert, M.L.; Yamada, K.; Huang, L.; Zhang, C.; Cooper, D.; Wang, Z; Yang, Y.; Suzuki, S.; Toyota, T.; Larner, J. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type 2 diabetic, Goto-Kakizaki rats. Proc. Natl. Acad. Sci. U. S. A., 1994, 91, 11040-11044.
28. Shashkin, P.N.; Shashkina, E.F.; Fernqvist-Forbes, E.; Zhou, Y. P.; Grill, V.; Katz, A. Insulin mediators in man: effects of glucose ingestion and insulin resistance. Diabetologia, 1997, 40, 557-563.
29. Baillargeon, J.P.; Iuorno, M.J.; Jakubowicz, D.J.; Apridonidze, T.; He, N.; Nestler, J.E. Metformin therapy increases insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 2004, 89, 242-249.
30. Scioscia, M.; Gumaa, K.; Kunjara, S.; Paine, M.; Selvaggi, L.; Rodeck, C.; Rademacher, T. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J. Clin. Endocrinol. Metab., 2006, 91, 709-717.
31. Larner, J.; Price, J.D.; Heimark, D.; Smith, L.; Rule, G.; Piccariello, T.; Fonteles, M.; Pontes, C.; Vale, D.; Huang, L. Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudodisaccharide Mn2+ chelate with insulin-like activity. J. Med. Chem., 2003, 46, 3283-3291.
32. Brautigan, D.L.; Brown, M.; Grindrod, S.; Chinigo, G.; Kruszewski, A.; Lukasik, S.; Bushweller, J.; Horal, M.; Keller, S.; Tamura, S.; Heimark, D.; Price, J.; Larner, A.; Larner, J. Allosteric activation of protein phosphatase 2C by d-chiro-inositolgalactosamine, a putative mediator mimetic of insulin action. Biochemistry, 2005, 44, 11067-11073.
33. Vassylyev, D.G.; Symersky, J. Crystal structure of pyruvate dehydrogenase phosphatase 1 and its implications. J. Mol. Biol., 2007, 370, 417-426.
34. Das, A.; Helps, N.; Cohen, P.; Barford, D. Crystal structure of the protein serine/threonine phosphatase 2C at 2.0 Å resolution. EMBO J., 1996, 15, 6798-6809.